You are here

Article Text

Article menu
Download PDFPDF
Learning from errors
CASE REPORT
Accessory bile duct: a rare but important anatomical variant
  1. Anthony S Casabianca1,
  2. Mihir M Shah2,
  3. Darren Carpizo2
  1. 1Department of General Surgery, Rutgers Robert Wood Johnson Medical School New Brunswick, New Brunswick, New Jersey, USA
  2. 2Department of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA
  1. Correspondence to Dr Anthony S Casabianca, a.casabianca{at}rutgers.edu

Summary

An 84-year-old man presented with pancreatic adenocarcinoma. Following neoadjuvant chemoradiation, the patient underwent a pancreaticoduodenectomy, complicated by early bile leak. Re-exploration and intraoperative cholangiogram identified an accessory common bile duct draining segment 5 of the right hepatic lobe, which was then ligated. The patient underwent a complicated postoperative course eventually developing sepsis secondary to biliary stasis. He elected for comfort measures and passed away secondary to complications of sepsis.

  • biliary intervention
  • cancer - see oncology
  • pancreas and biliary tract

https://doi.org/10.1136/bcr-2018-225133

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors ASC and MMS: conducted the background research and initial drafting of the manuscript with significant input and editorial guidance from DC. MMS and DC: conducted the surgical procedures mentioned in the study and conceptualised the report. All three authors had full access to the data and reports at all times and have all seen and agreed upon the final draft for submission.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.